-
MD Anderson Cutting Staff by 1,000
University of Texas – MD Anderson Cancer Center in Houston says it is cutting its workforce by about 1,000, about 5 percent of its staff. Most of the cuts, 800 to 900 jobs, will be done by layoffs.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
-
Technique Uses Light to Activate Drugs in Blood Cells
A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations.
-
Gene Expression Changes Found in Wound Healing Therapy
A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue.
-
Solar Cells Shown Feasible to Power Medical Implants
Biomedical engineers in Switzerland built and field-tested small solar cells that generated enough energy for implanted medical devices like heart pacemakers.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Antibody Trials Stopped After Deaths Reported
The U.S. Food and Drug Administration halted early-stage clinical trials of a monoclonal antibody drug for leukemia after four deaths occurred from liver toxicity.
-
New Year, 2017
It’s the new year holiday in the U.S. today, so Science & Enterprise is taking the day off as well.
-
Trial to Test Stem Cells for Treating Heart Failure
A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites.